November 2022

 Abdelsalam, S., Livingston, M., Quinn, B., Agius, P., Ward, B., Jamieson, L. and Dietze, P. (2022). Risk factors for poor oral health related quality of life in a cohort of people who use methamphetamine in Australia. Drug and Alcohol Review.

Acheson, L. S., Ezard, N., Lintzeris, N., Dunlop, A., Brett, J., Rodgers, C., . . . Siefried, K. J. (2022a). Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial. DRUG AND ALCOHOL DEPENDENCE, 109692. doi:10.1016/j.drugalcdep.2022.109692

Acheson, L. S., Ezard, N., Lintzeris, N., Dunlop, A., Brett, J., Rodgers, C., . . . Siefried, K. J. (2022b). Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal. PLOS ONE, 17(10 October). doi:10.1371/journal.pone.0275371

Andrews, J., Birrell, L., Chapman, C., Teesson, M., Newton, N.C., Allsop, S., McBride, N., Hides, L., Andrews, G., Olsen, N., Mewton, L. and Slade, T. (2022). Evaluating the effectiveness of a universal eHealth school-based prevention program for depression and anxiety, and moderating role of friendship network characteristics. Psychological Medicine. pp. 1-10. DOI:

Beck, A. K., Larance, B., Manning, V., Hides, L., Baker, A. L., Deane, F. P., . . . Kelly, P. J. (2022). Online SMART Recovery mutual support groups: Characteristics and experience of adults seeking treatment for methamphetamine compared to those seeking treatment for other addictive behaviours. DRUG AND ALCOHOL REVIEW. doi:10.1111/dar.13544

Booth, L., Jongenelis, M., Drane, C., Brennan, E., Wakefield, M., Chikritzhs, T.N., Hasking, P. and Pettigrew, S. (2022). Understanding and Overcoming Barriers to Drink Counting. Substance Use and Misuse. DOI:

Bowden, J., Harrison, N.J., Caruso, J. Room, R., Pettigrew, S., Olver, I., Miller, C. Which drinkers have changed their alcohol consumption due to energy content concerns? An Australian survey. BMC Public Health, 1775 (2022).

Brownlea, S., Miller, J., Taylor, N., Miller, P.G., Coomber, K., Baldwin, R. and Palmer, D. (2022). Impact of alcohol policy changes on substance-affected patients attending an Emergency Department in the Northern Territory with police. Emergency Medicine Australasia. [In Press] DOI:

Camacho, X., Zoega, H., Gomes, T., Schaffer, A. L., Henry, D., Pearson, S. A., . . . Havard, A. (2022). The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions. International Journal of Epidemiology. doi:10.1093/ije/dyac180

Cheetham, A., Morgan, K., Jackson, J., Lord, S., & Nielsen, S. (2022). Informing a collaborative-care model for delivering medication assisted treatment for opioid dependence (MATOD): An analysis of pharmacist, prescriber and patient perceptions. Research in Social and Administrative Pharmacy. doi:10.1016/j.sapharm.2022.09.009

Chrzanowska, A., Man, N., Akhurst, J., Sutherland, R., Degenhardt, L., & Peacock, A. (2022). Trends in drug-related hospitalisations in Australia, 1999-2021. Retrieved from Sydney:

Cleary, J., Nolan, C., Guhn, M., Thomson, K. C., Barker, S., Deane, C., . . . Olsson, C. A. (2022). A study protocol for community implementation of a new mental health monitoring system spanning early childhood to young adulthood. Longitudinal and Life Course Studies, 1-20. doi:10.1332/175795921x16599509057666

Darke, S., Duflou, J., Peacock, A., Chrzanowska, A., Farrell, M., & Lappin, J. (2022). Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021. ADDICTION. doi:10.1111/add.16055

Day, C. A., Salmon, A., Jauncey, M., Bartlett, M., & Roxburgh, A. (2022). Twenty-one years at the Uniting Medically Supervised Injecting Centre, Sydney: addressing the remaining questions. Medical Journal of Australia, 217(8), 385-387. doi:10.5694/mja2.51716

de Andrade, D., Button, K., Coomber, K., Taylor, N., Ferris, J., Curtis, A. and Miller, P.G. (2022). Investigating the relationship between inaccurate blood alcohol concentration estimates, harm and other negative consequences. Drug and Alcohol Review. [In Press] DOI:

Degan, T. J., Robinson, L. D., Deane, F. P., Baker, A. L., & Kelly, P. J. (2022). Post-treatment Outcomes and Changes in Health Literacy of People Discharged from Specialist Substance Use Disorder Treatment Services. International Journal of Mental Health and Addiction. doi:10.1007/s11469-022-00915-w

Duncan, D., Moore, D., Keane, H. and Ekendahl, M. (2022). Obscuring Gendered Difference: The Treatment of Violence in Australian Government Alcohol Policy. Social Politics, 29, (3), pp. 1057-1079. DOI:

Ezard, N., Lintzeris, N., Dunlop, A., Brett, J., Rodgers, C., Gill, A., Christmass, M., McKetin, R., Farrell, M., Shoptaw, S. and Siefried, K.J. (2022). Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal. PloS One, 17, (10). DOI:

Fischer, B., Lindner, S. R., & Hall, W. (2022). Cannabis use and public health: time for a comprehensive harm-to-others framework. The Lancet Public Health, 7(10), e808-e809. doi:10.1016/S2468-2667(22)00205-5

Fomiatti, R., Farrugia, A.C., Fraser, S., Moore, D., Edwards, M. and Treloar, C. (2022). Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment. Time & Society. DOI:

Francia, L., Berg, A., Lam, T., Morgan, K., & Nielsen, S. (2022). “The peer workers, they get it”–how lived experience expertise strengthens therapeutic alliances and alcohol and other drug treatment-seeking in the hospital setting. Addiction Research and Theory. doi:10.1080/16066359.2022.2124245

Francia, L., Lam, T., Berg, A., Morgan, K., Savic, M., Lubman, D. I., & Nielsen, S. (2022). Putting out the welcome mat—A qualitative exploration of service delivery processes and procedures as barriers to treatment-seeking for people who use alcohol and other drugs. DRUG AND ALCOHOL REVIEW. doi:10.1111/dar.13551

Freeman, G., Siefried, K. J., Roberts, D. M., Rodgers, C., Nic Ionmhain, U., Ramanathan, J., . . . Brett, J. (2022). Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series. DRUG AND ALCOHOL REVIEW. doi:10.1111/dar.13556

Gaddis, N., Mathur, R., Marks, J., Zhou, L., Quach, B., Waldrop, A., . . . Johnson, E. O. (2022). Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. Scientific Reports, 12(1). doi:10.1038/s41598-022-21003-y

Hall, W. D., & Humphreys, K. (2022). Is good science leading the way in the therapeutic use of psychedelic drugs? Psychological Medicine, 1-3. doi:10.1017/s0033291722003191

Howard, B. C., McRobbie, H., Petrie, D., Barker, D., Mendelsohn, C., Anderson, J., . . . Courtney, R. J. (2022). Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial. TRIALS, 23(1). doi:10.1186/s13063-022-06644-8

Jackson, M. A., Buykx, P., Brown, A. L., Baker, A. L., Dunlop, A. J., & Gould, G. S. (2022). Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services. Addiction Science and Clinical Practice, 17(1). doi:10.1186/s13722-022-00337-y

Johnson, B., Co, S., Sun, T., Lim, C. C. W., Stjepanović, D., Leung, J., . . . Chan, G. C. K. (2023). Cryptocurrency trading and its associations with gambling and mental health: A scoping review. Addictive Behaviors, 136. doi:10.1016/j.addbeh.2022.107504

Jung, M., Lukose, D., Nielsen, S., Bell, J. S., Webb, G. I., & Ilomäki, J. (2022). COVID‐19 restrictions and the incidence and prevalence of prescription opioid use in Australia – a nation‐wide study. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15577

Laslett, A.L. (2022). Commentary on Bischof et al.: Empirical and conceptual paradigms for studying secondary impacts of a person's substance use. Addiction. DOI:

Lee, K.S., Bullen, L., Zheng, C., Dawson, A., Munro, A. and Conigrave, K. (2022). Beliefs and attitudes of drug and alcohol clinicians when considering referral of Aboriginal clients to involuntary drug and alcohol treatment: A qualitative study. Drug and Alcohol Review.

Lowrie, N., Le Bas, G., Youssef, G., Macdonald, J. A., Teague, S., Rogers, A., . . . Hutchinson, D. (2022). Association of adolescent and young adult depression and anxiety with perinatal mental health in fathers: Findings from an Australian longitudinal study. Journal of Psychiatric Research, 156, 206-213. doi:10.1016/j.jpsychires.2022.10.017

Lubman, D. I., Grigg, J., Reynolds, J., Hall, K., Baker, A. L., Staiger, P. K., . . . Manning, V. (2022). Effectiveness of a Stand-alone Telephone-Delivered Intervention for Reducing Problem Alcohol Use: A Randomized Clinical Trial. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2022.2779

McCarter, K., McKinlay, M. L., Cocks, N., Brasier, C., Hayes, L., Baker, A. L., . . . Brophy, L. (2022). The value of compassionate support to address smoking: A qualitative study with people who experience severe mental illness. Frontiers in Psychiatry, 13. doi:10.3389/fpsyt.2022.868032

McEntee A, Hines S, Trigg J, Fairweather K, Guillaumier A, Fischer J, Bonevski B, Smith JA, Wilson C, and Bowden J. Tobacco cessation and screening in culturally and linguistically diverse communities: an Evidence Check rapid review brokered by the Sax Institute for Cancer Council NSW, 2022. doi:10.57022/sneg4189

Miller, P., Vakidis, T., Taylor, N., Baker, T., Stella, J., Egerton-Warburton, D., . . . Bumpstead, S. (2022). Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre study. Australian and New Zealand Journal of Public Health. doi:10.1111/1753-6405.13303

Mills, L., Dunlop, A., Montebello, M., Copeland, J., Bruno, R., Jefferies, M., . . . Lintzeris, N. (2022). Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Substance Abuse: Treatment, Prevention, and Policy, 17(1). doi:10.1186/s13011-022-00493-z

Myring, G., Lim, A. G., Hollingworth, W., McLeod, H., Beer, L., Vickerman, P., . . . Dillon, J. F. (2022). Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial. Journal of Infection. doi:10.1016/j.jinf.2022.09.021

Olsson, C. A., Letcher, P., Greenwood, C. J., McIntosh, J. E., Barker, S., Olsson, C. M., . . . Sanson, A. V. (2022). The Australian Temperament Project Generation 3 study: a population-based multigenerational prospective cohort study of socioemotional health and development. BMJ OPEN, 12(9), e061854. doi:10.1136/bmjopen-2022-061854

Palmateer, N., Hamill, V., Bergenstrom, A., Bloomfield, H., Gordon, L., Stone, J., . . . Hutchinson, S. (2022). Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020). INTERNATIONAL JOURNAL OF DRUG POLICY, 109. doi:10.1016/j.drugpo.2022.103872

Parmenter, B.J., Burley, C., Stewart, C., Whife, J., Champion, K.E., Osman, B., Newton, N.C., Green, O., Wescott, A.B., Gardner, L.A., Visontay, R., Birrell, L., Bryant, Z., Chapman, C., Lubman, D., Sunderland, M., Slade, T. and Thornton, L. (2022). Measurement Properties of Smartphone Approaches to Assess Physical Activity in Healthy Young People: Systematic Review. JMIR mHealth and u Health. DOI:

Pearce, T., Maple, M., Wayland, S., McKay, K., Shakeshaft, A., & Woodward, A. (2022). Evidence of co-creation practices in suicide prevention in government policy: a directed and summative content analysis. BMC Public Health, 22(1). doi:10.1186/s12889-022-14313-3

Picco, L., Sanfilippo, P., Xia, T., Lam, T., & Nielsen, S. (2022). How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment. INTERNATIONAL JOURNAL OF DRUG POLICY, 109. doi:10.1016/j.drugpo.2022.103856

Raggatt, M., Douglass, C.H., Wright, C., Reddan, H., O'Connell, H., Dietze, P. and Lim, M. (2022). Music festival attendees' transport mode and beliefs about alcohol and illicit drug use before driving in Victoria, Australia. Drugs: Education, Prevention and Policy. DOI:

Robinson, L. D., Walter, E. E., Deane, F. P., & Larance, B. K. (2022). Comorbid eating disorders among women receiving treatment for substance use disorders: a systematic review and meta-analysis. Addiction Research and Theory. doi:10.1080/16066359.2022.2127692

Roxburgh, A., & Nielsen, S. (2022). Twenty-year trends in pharmaceutical fentanyl and illicit fentanyl deaths, Australia 2001–2021. INTERNATIONAL JOURNAL OF DRUG POLICY, 109. doi:10.1016/j.drugpo.2022.103854

Stam, N. C., Cogger, S., Schumann, J. L., Weeks, A., Roxburgh, A., Dietze, P. M., & Clark, N. (2022). The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia. Clinical Toxicology. doi:10.1080/15563650.2022.2126371

Stearne, A. (2022). Alcohol policy and self-determination in the Northern Territory. Do First Nations Australians have the right? Drug and Alcohol Review.

Stearne, A., Lee, K.S., Allsop, S., Shakeshaft, A.P. and Wright, M. (2022). Self-determination by First Nations Australians in alcohol policy: lessons from Mbantua/Alice Springs (Northern Territory, Australia). International Journal of Drug Policy, 108, pp. 103822. DOI:

Stone, J., Fraser, H., Walker, J. G., Mafirakureva, N., Mundia, B., Cleland, C., . . . Vickerman, P. (2022). Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya. AIDS, Publish Ahead of Print. doi:10.1097/qad.0000000000003382

Stone, J., Lim, A. G., Dore, G. J., Borquez, A., Geddes, L., Gray, R., . . . Vickerman, P. (2022). Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: a modelling study. Liver International. doi:10.1111/liv.15469

Sutherland, R., Karlsson, A., King, C., Jones, F., Uporova, J., Price, O., . . . Peacock, A. (2022). Australian Drug Trends 2022: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews. Retrieved from Sydney:

Sutherland, R., Karlsson, A., King, C., Jones, F., Uporova, J., Price, O., . . . Peacock, A. (2022). Australian Drug Trends 2022: Key Findings from the National Ecstasy and Related Drugs Reporting System (EDRS) Interviews. Retrieved from Sydney:

Sutherland, R., Uporova, J., King, C., Jones, F., Karlsson, A., Gibbs, D., Price, O., Bruno, R., Dietze, P., Lenton, S., Salom, C.L., Daly, C., Thomas, N., Juckel, J., Agramunt, S., Wilson, Y., Que Noy, W., Wilson, J., Degenhardt, L., Farrell, M. and Peacock, A. (2022). Australian Drug Trends 2022: Key Findings from the National Illicit Drug Reporting System (IDRS) Interviews. National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW.

Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P. M., Baker, P., Bruno, R., . . . Bright, S. J. (2022). Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review. Journal of Psychopharmacology. doi:10.1177/02698811221127954

Thornton, L., Brown, H., Osman, B., Stewart, C., Whife, J., Champion, K.E., Gardner, L.A., McBride, N., Allsop, S., Spring, B. and Teesson, M. (2022). Factors associated with adolescents’ engagement with a Healthy Lifestyles app, 206, pp. 56-67. DOI:

Tremonti, C., & Nielsen, S. (2022). The emerging issue of Kamini: A new source of opioid dependence. DRUG AND ALCOHOL REVIEW. doi:10.1111/dar.13552

Tse, W. C., Scott, N., Dietze, P., & Nielsen, S. (2022). Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths. Journal of Substance Abuse Treatment, 143. doi:10.1016/j.jsat.2022.108871

Tucker, D., Symons, M., Clifton, E., Ramirez, M., Fitzpatrick, J., Walker, R., Pearson, G., Gray, M., Kirby, G. and McBride, N. (2022). Assessing The Validity Of A Culturally Modified Drinking Motives Questionnaire For Use In Aboriginal Communities. Journal of the Australian Indigenous HealthInfoNet, 3, (4). DOI:

Valerio, H., Conway, A., Alavi, M., Treloar, C., Silk, D., Murray, C., . . . Grebely, J. (2022). Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study. INTERNATIONAL JOURNAL OF DRUG POLICY, 110. doi:10.1016/j.drugpo.2022.103876

Walker, S., Curtis, M., Woods, E., Pierce, L., Kirwan, A., Stewart, A. C., . . . Stoové, M. (2022). Reflections on the in-prison recruitment and participation of men with a history of injecting drug use, in a longitudinal cohort study in Australia. JOURNAL OF CRIMINOLOGY. doi:10.1177/26338076221127047

Weatherburn, D. (2022). Interjurisdictional differences in Australian imprisonment rates: Sentencing or arrest rates? JOURNAL OF CRIMINOLOGY. doi:10.1177/26338076221128997

Yuen, W. S., Peacock, A., Man, N., Callinan, S., Slade, T., Farrell, M., . . . Livingston, M. (2022). Age, period and cohort effects on alcohol-related risky behaviours in Australia from 2001 to 2016. ADDICTION. doi:10.1111/add.16061

Zolopa, C., Brothers, T. D., Leclerc, P., Mary, J. F., Morissette, C., Bruneau, J., . . . Larney, S. (2022). Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study. INTERNATIONAL JOURNAL OF DRUG POLICY, 110. doi:10.1016/j.drugpo.2022.103894